Skip to search formSkip to main contentSkip to account menu

AGI-1067

Known as: AGI 1067, AGI1067 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

succinobucol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ortaöğretim Türk Dili ve Edebiyatı Dersinde Eğitim Bilişim Ağı'nın Kullanımına Yönelik Öğrenci Görüşlerine Yönelik Bir Durum Çalışması
Bu arastirmanin amaci Turk dili ve edebiyati dersi egitim-ogretim surecinin etkililiginin arttirilmasi icin Egitim Bilisim Agi… 
2015
2015
A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.
The cell type that normally limits the inflammatory and atherosclerotic process is the vascular endothelial cell (EC) that can be… 
Review
2006
Review
2006
AGI-1067: A Novel Vascular Protectant for Prevention of Restenosis
Objective: To review the synthesis, pharmacology, clinical trials, and adverse effects of AGI-1067, a novel agent for preventing… 
Highly Cited
2004
Highly Cited
2004
Selective Inhibition of Endothelial and Monocyte Redox-Sensitive Genes by AGI-1067: A Novel Antioxidant and Anti-Inflammatory Agent
Atherosclerosis is a disease of oxidative stress and inflammation. AGI-1067 [butanedioic acid, mono[4-[[1-[[3,5-bis(1,1… 
Highly Cited
2003
Highly Cited
2003
AGI-1067: A Multifunctional Phenolic Antioxidant, Lipid Modulator, Anti-Inflammatory and Antiatherosclerotic Agent
To explore the therapeutic efficacy and potential mechanisms of action of a new class of antiatherosclerotic drugs, AGI-1067… 
Review
2003
Review
2003
Clinical results with AGI-1067: a novel antioxidant vascular protectant.
Review
2003
Review
2003
Vascular protectants for the treatment of atherosclerosis
AGI1067, the monosuccinic acid ester of probucol, is a phenolic antioxidant member of a novel class of agents termed vascular… 
Review
2002
Review
2002
Prevention of Restenosis with Antioxidants
The aim of this review is to give an overview of the field of restenosis prevention with antioxidants, put in the perspective of… 
2002
2002
AGI-1067. AtheroGenics.
AGI-1067 is an oral VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor under development by AtheroGenics for… 
Review
2002
Review
2002
Prevention of restenosis with antioxidants: mechanisms and implications.
The aim of this review is to give an overview of the field of restenosis prevention with antioxidants, put in the perspective of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)